Rare diseases
Investigational molecules
Locations
Back to France1 508 clinical trials in Quint-Fonsegrives, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Open-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy
FranceObrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients
FranceA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
FranceZenagamtide for Weight Loss in Adults with Obesity
FranceBelzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
FranceAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
FranceFrexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients
FranceTreatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia
FranceA study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.
FranceA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
FranceA study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy
FranceA study of PM54 and pembrolizumab in adults with advanced cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies for both muscle-invasive and non-muscle-invasive cases. Studies also address prostate conditions, from benign hyperplasia to advanced cancer.
Novel approaches combine immunotherapy with targeted treatments to improve patient outcomes.
Comprehensive research into breast cancer treatments, particularly focusing on triple-negative and hormone receptor-positive variants. Studies evaluate new approaches in colon cancer management using circulating tumor DNA analysis.
Investigations combine immunotherapy with traditional treatments for enhanced efficacy.
Research addressing pulmonary conditions and specialized medical needs. Studies include evaluation of treatments for chronic obstructive pulmonary disease and migraine management in emergency settings.
Focus on improving patient quality of life through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
